Quick Look at ABBVABBV sitting at resistance currently after a bump up this past weekby Urameshi_Trades0
$ABBV Bearish Swing Trade PlanGreen Line - Entry Target Red Line - Exit Target Pink Line - Stop-Loss Highly suggest using Google to Search "Transparent Traders" if you're trying to get to the next level. Transparent Traders exists to solve the critical issues facing our traders, both large and small. Our unique approach is not only what differentiates us, but also what makes us successful. Our advanced Blackbox uses custom algorithms & predictive A.I. to locate the most accurate day or swing trades for the best chance of success. Shortby jonny_red321
$ABBV Can Buffett get ABBvie to rally. ? Potential breakout in play for ABBV as investors may chase The Oracle Warren Buffett into the stock. Stock was already on the verge of making a move so this may be the catalyst needed. Longby Bullishcharts11
ABBV - Daily inside candle. Look for a break above or below today's high or low to then go on to my upper or lower targets. by kojak140
$ABBV posted a less than expected earningsPEAD projected a negative outlook for $ABBV after the later posted less than expected earnings with the price currently trading close to the upper boundary. If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.Shortby EPSMomentum0
AbbVie Dropping. NYSE:ABBVBeginning to sound like a broken record. I am enjoying seeing how the patterns more or less repeats itself within a major industry sector. Like the currencies against USD are doing a similar thing, so do major pharma stocks. Anyway, Fib goals traced, not financial advice.Shortby Rykin_CapitalUpdated 1
ABBV Long, DemandDown below a support line Touched Demand zone. Entry 80 Stop 78 Target 88 reward:risk=4:1 Stock traders better wait. Earning date 10/30 7AM I am not a PRO trader. I need few months to practice trading strategies. If you like this idea, please use SIM/Demo account to try it, until my trading plans get high winning rate.Longby PlanTradePlanMMUpdated 3
ABBV, is it a buy right now?βοΈ Losing patent protection for a top-selling blockbuster drug is a big setback for any pharmaceutical company, but this can also give us great opportunities. They have done a great strategic-movement by acquiring Allergan. It's down 18% from last July 17 high, earnings are close. I believe, yes, it's a good moment to START doing COST-AVERAGE. The price is almost getting closer to the 50% Fibonacci (from last Mar 20). I'm protecting an optimistic retracement to 127% (at $108.58) Fibonacci (drawing from today), very close to the analyst's current average price target at $109.21. A more conservative take profit would be at $95. - P/E GAAP (TTM) of 18.63, sector media of 35.57 π - Forward P/E of 6.94 π - PEG GAAP (TTM) of 0.29, sector media of 0.88 π - EV / EBITDA (TTM) of 13.76 in a sector media of 19.29 π - Debt / Eq of 5.4 π - Dividend yield of 5.60% π Nothing else to say, it's a great company, with great dividends. I'm in! π This isn't trading advice. I've no idea what I'm talking about π. Trade with caution! π¨ Have a good day! π€Longby UnknownUnicorn12013771112
$ABBV AbbVie Inc. - Double Bottom, Bullish Options Activity$ABBV AbbVie Inc. - Looking like a possible double bottom just under $86 after about a two month bear move. Expecting a strong move in the near term once this can clear the 200d ema (currently ~$89.00). Note: earnings upcoming, expected 10/30/20. Huge Bullish Options Flow in this name today: $122M in January'21 calls traded today (varying strikes, most deep ITM), on avg 8x OI - 58k contracts in total. Definitely looks like a large hedge fund trade. Positive fundamental news out today (possible driver of bullish options activity): "The National Institutes of Health said is running a mid-stage clinical trial evaluating a monoclonal antibody it developed with the privately held Boehringer Ingelheim in combination with remdesivir as a COVID-19 treatment." Source: MarketWatch.com -> www.marketwatch.com Medium term target: $107 by year-end Note: This is NOT investment advice.Longby Triple_Barrel_Capital339
Abbvie short term bullish trade idea Abbvie has progressed towards its previous resistance and looks to be testing its last high. I am planning on watching for a bullish move that breaks this resistance and will hold the trade until the RSI trend line is broken or until the Fibonacci take profit zones have been reached. Dont be surprised if it takes a day or two to develop but the time frame of occurrence I expect will be between now and the end of the week. Longby Avatar_Trading111
ABBVIE daily analysisHi friends the daily chart shows that it will experience a downward trend in the next few days with a very high probability but at the same time it is better to be vigilant of the change from the direction to the opposite please subscribe to receive more analyzesShortby YL_PRO112
ABBV pull back levelsAfter breaking the wedge looking to get in at support levels. 90 is the first areaLongby ghostdiggUpdated 1